Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
TSRO

Tesaro

$34.84

8.27 (31.13%)

, CLVS

Clovis

$16.84

1.41 (9.14%)

15:59
11/16/18
11/16
15:59
11/16/18
15:59
Periodicals
Tesaro said to work with advisors after receiving interest, Bloomberg says »

Tesaro (TSRO) is looking…

TSRO

Tesaro

$34.84

8.27 (31.13%)

CLVS

Clovis

$16.84

1.41 (9.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

TSRO

Tesaro

$29.17

2.6 (9.79%)

, CLVS

Clovis

$16.83

1.4 (9.07%)

15:07
11/16/18
11/16
15:07
11/16/18
15:07
Hot Stocks
Tesaro resumes, up 35% after report of exploring sale »

Peer Clovis (CLVS) is up…

TSRO

Tesaro

$29.17

2.6 (9.79%)

CLVS

Clovis

$16.83

1.4 (9.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

TSRO

Tesaro

$27.48

0.91 (3.42%)

, CLVS

Clovis

$15.74

0.31 (2.01%)

14:59
11/16/18
11/16
14:59
11/16/18
14:59
Hot Stocks
Tesaro jumps after report of sale exploration, peer Clovis follows »

Shares of Tesaro (TSRO)…

TSRO

Tesaro

$27.48

0.91 (3.42%)

CLVS

Clovis

$15.74

0.31 (2.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

CLVS

Clovis

$15.77

0.34 (2.20%)

, TSRO

Tesaro

$27.60

1.03 (3.88%)

14:55
11/16/18
11/16
14:55
11/16/18
14:55
Hot Stocks
Breaking Hot Stocks news story on Clovis, Tesaro »

Clovis jumps 9% to $16.87…

CLVS

Clovis

$15.77

0.34 (2.20%)

TSRO

Tesaro

$27.60

1.03 (3.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

RHHBY

Roche

$0.00

(0.00%)

08:23
11/16/18
11/16
08:23
11/16/18
08:23
Conference/Events
Roche has a conference call hosted by JPMorgan »

JPMorgan Analyst Vosser…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Dec

  • 24

    Dec

CRL

Charles River

$130.56

1.96 (1.52%)

, CRVS

Corvus Pharmaceuticals

$6.91

0.11 (1.62%)

04:55
11/16/18
11/16
04:55
11/16/18
04:55
Conference/Events
European Organization for Research & Treatment of Cancer to hold symposium »

The European Organization…

CRL

Charles River

$130.56

1.96 (1.52%)

CRVS

Corvus Pharmaceuticals

$6.91

0.11 (1.62%)

XCUR

Exicure

$0.00

(0.00%)

ZYME

Zymeworks

$12.82

0.075 (0.59%)

ARWR

Arrowhead

$12.97

0.92 (7.63%)

ALRN

Aileron Therapeutics

$2.24

0.135 (6.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 27

    Nov

Thursday
AVEO

Aveo Pharmaceuticals

$1.86

-0.04 (-2.11%)

13:01
11/15/18
11/15
13:01
11/15/18
13:01
Recommendations
Aveo Pharmaceuticals analyst commentary at Piper Jaffray »

Piper Jaffray sees FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

LOXO

Loxo Oncology

$147.40

3.71 (2.58%)

11:25
11/15/18
11/15
11:25
11/15/18
11:25
Conference/Events
Loxo Oncology management to meet with Morgan Stanley »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 26

    Nov

  • 27

    Nov

AVEO

Aveo Pharmaceuticals

$1.90

0.045 (2.43%)

07:04
11/15/18
11/15
07:04
11/15/18
07:04
Hot Stocks
Aveo Oncology announces $2M milestone payment from EUSA Pharma »

AVEO Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

EXEL

Exelixis

$16.75

0.09 (0.54%)

, IPSEY

Ipsen

$0.00

(0.00%)

05:20
11/15/18
11/15
05:20
11/15/18
05:20
Hot Stocks
Exelixis receives EC approval for Cabometyx tablets »

Exelixis (EXEL) announced…

EXEL

Exelixis

$16.75

0.09 (0.54%)

IPSEY

Ipsen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 27

    Nov

  • 14

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.